Our Expertise

Below is a list of therapy areas we have already worked on:

• CARDIOLOGY (Cholesterol Management, ACS, Atrial Fibrillation, Pacemakers, Anticoagulation, Cardiac Imaging Devices)
  
  
• DERMATOLOGY (Psoriasis, Psoriasis-Arthritis, Atopic Dermatitis, Acne)
  
  
• ENDOCRINOLOGY (Diabetes Management, Osteoporosis)
  
  
• GASTROENTEROLOGY (Crohn's Disease, Ulcerative Colitis, IBS,  [Chronic] Constipation)
  
  
• HEMATOLOGY (Acute and Chronic Leukemia, Hairy Cell Leukemia, Myelofibrosis, Hemophilia A + B)
  
  
• INFECTIOUS DISEASES (HCV, HIV, Shingles)
  
  
• NEPHROLOGY (Renal Anemia, Renal Transplantation)
  
  
• NEUROLOGY (Epilepsy, Dravet Syndrome, Migraine, MS, Alzheimer's Disease, Parkinson Disease)
  
  
• ONCOLOGY (Breast Cancer, Hodgkin's Lymphoma, NSCLC, Prostate Cancer, Biliary Tract Cancer, Bladder Cancer, Bowel Cancer, Ovarian Cancer, Stomach Cancer, Lymphoma)
  
  
• OPHTHALMOLOGY (Glaucoma, RVO, Conjunctivitis, Eye Cataract, Retinal Detachment, Dry Eyes)
  
  
• PSYCHIATRY (ADHD, Bipolar Disorder, Depression, Schizophrenia)
  
  
• PULMONOLOGY (Asthma, COPD, Pulmonary Hypertension, Smoking Cessation, Alpha 1-Antitrypsin Deficiency)
  
  
• RHEUMATOLOGY (Rheumatoid Arthritis, Osteoporosis)
  
  
• SURGERY (Breast Reconstruction, Wound Care)
  
  
• UROLOGY (OAB, Urinary Incontinence, Bladder Infections)
  
  
• OTHERS (Botulinum Toxins, Dermal Fillers, Vaccinations, HAE, Familial Mediterranean Fever, Alpha-1-Antitrypsin Deficiency)

And below is a brief overview of research subjects we have already covered when interviewing HCPs or patients:

• Exploring prescription behaviour and therapy pathways
• Exploring unmet needs and challenges with current treatments
• Exploring perceptions of current and reactions to future treatments, including how future treatments may change the prescription behaviour
• Exploring promotion materials such as creative concepts or detail aids
• Exploring HCPs-patients conversations, interactions and relationships
• Exploring patient journeys, including identification of key milestones, challenges and emotional states
• Exploring levels of patient disease burden and coping strategies of patients